Sign in

CIK 0000879407 · Large accelerated filer

ARROWHEAD PHARMACEUTICALS, INC.

Sign in to watch
Ticker
ARWR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Sep 30
Incorporated
DE
Entity type
operating
EIN
460408024
Phone
626-696-4702
Business address
177 E COLORADO BLVD, SUITE 700, PASADENA, CA, 91105
Former names
ARROWHEAD RESEARCH CORP, INTERACTIVE GROUP INC, INTERACTIVE INC
  1. 4 Open-market sale Chief Executive Officer sold 85,000 shares at an average $64.04 ($5,443,462)
  2. 4 Grant or award Director acquired 7,819 shares (grant or award)
  3. 4 Grant or award Director acquired 7,819 shares (grant or award)
  4. 4 Grant or award Director acquired 7,819 shares (grant or award)
  5. 4 Grant or award Director acquired 7,819 shares (grant or award)
  6. 4 Grant or award Director acquired 7,819 shares (grant or award)
  7. 4 Grant or award Director acquired 7,819 shares (grant or award)
  8. 4 Grant or award Director acquired 7,819 shares (grant or award)
  9. 4 Open-market sale Chief Executive Officer sold 184,298 shares at an average $67.00 ($12,348,802)
  10. 4 Open-market sale Director sold 16,250 shares at $61.03 ($991,738)
  11. 4 Open-market sale Director sold 8,750 shares at $56.39 ($493,413)
  12. 4 Planned sale Chief Medical Officer sold 20,000 shares at $35.00 ($700,000)
  13. 4 Planned sale Chief Medical Officer sold 15,000 shares at $30.00 ($450,000)
  14. 4 Planned sale Chief Medical Officer sold 15,000 shares at $25.00 ($375,000)
  15. 4 Planned sale Chief Medical Officer sold 10,000 shares at $20.00 ($200,000)
  16. 3 Insider Initial Statement of Ownership
  17. 4 Open-market sale Chief Executive Officer sold 141,122 shares at an average $10.87 ($1,533,337)
  18. 4 Open-market sale Chief Executive Officer sold 51,425 shares at $15.07 ($774,975)
  19. 4 Planned sale Chief Executive Officer sold 300,000 shares at an average $17.58 ($5,274,334)
  20. 4 Grant or award Chief Executive Officer acquired 9,550 shares (grant or award)

Page 2 of 25 · 497 filings